Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD476 (Lialda) for Prevention of Recurrent Diverticulitis
NCT00545740Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2007
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of Salcrozine in diverticulitis, sponsored by Takeda. Started Nov 2007; status: completed.
02
Drugs
Salcrozine
03
Conditions
diverticulitis
Beyond the preview
Go deeper on NCT00545740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545740.